Free Trial

Alkermes (ALKS) News Today

Alkermes logo
$47.89 +1.42 (+3.06%)
Closing price 04:00 PM Eastern
Extended Trading
$47.90 +0.01 (+0.01%)
As of 07:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Why Is Alkermes Up Today?

Alkermes plc (NASDAQ: ALKS): HC Wainwright’s earnings revisions point to a brighter longer-term outlook, tempered by a lower near-term estimate and a Neutral rating. The updates could be a modest positive overall.

  • Positive Sentiment: HC Wainwright raised its full-year EPS forecasts for 2026 through 2030: it now projects a narrower 2026 loss of $0.56 per share, followed by earnings of $0.24 in 2027, $0.08 in 2028, $0.86 in 2029 and $1.66 in 2030. The biggest increases were for 2027–2030, suggesting improved expectations for the longer-term earnings trajectory.
  • Neutral Sentiment: Despite the improved forecasts, HC Wainwright maintained its Neutral rating and $50 price target, indicating a measured stance rather than a strong endorsement.
  • Negative Sentiment: HC Wainwright cut its Q4 2026 EPS estimate to a loss of $0.28 from a loss of $0.23, signaling weaker expectations for that quarter.
  • Neutral Sentiment: A separate report showed short interest at zero shares as of November 10. That may suggest little reported bearish positioning, though the figure could reflect a data anomaly.
Posted 4h agoAI Generated. May Contain Errors.

Alkermes Latest News

Alkermes Stock Earnings Estimates Boosted by HC Wainwright
Alkermes plc (ALKS) - What Are Investment Firms Saying About This Stock?
Alkermes (NASDAQ:ALKS) Price Target Raised to $50.00
Alkermes to Present at Upcoming Investor Conferences
Alkermes plc Reports Third Quarter 2026 Financial Results
Alkermes plc (ALKS) Q3 2026 Earnings Call Transcript
Alkermes plc
Alkermes (ALKS) Q3 2026 Earnings Call Transcript
What Alkermes (ALKS) Said on Its Q3 Earnings Call
Alkermes (ALKS) Receives a Buy from Needham
Alkermes (ALKS) Gets a Hold from Goldman Sachs
RBC Capital Reaffirms Their Buy Rating on Alkermes (ALKS)

Alkermes Media Mentions By Week

Alkermes Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ALKS
News Sentiment
▼
0.86

0.57
▲
Average
Healthcare
News Sentiment

Alkermes News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ALKS Articles
This Week
▼
16

6
▲
ALKS Articles
Average Week

Alkermes Trends on MarketBeat

This week vs. last week
New Followers
1
Searches
2
Page Views
1,460
-53%
Get Alkermes News Delivered to You Automatically

Sign up to receive the latest news and ratings for ALKS and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


MarketBeat tracks news from more than one hundred trusted media outlets in real time, with the most recent headline for Alkermes dated 11/11/2026.
From Our Partners